Becton Dickinson and Company

Healthcare · Medical Instruments & Supplies

183.80$ +2.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Becton Dickinson and Company (BDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 4,983 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BDX
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	3,231	2,922	2,969	3,035	3,166	3,080	4,222	4,278	4,402	4,160	4,195	4,350	4,584	4,225	4,253	3,855	4,784	5,315	4,907	4,607	5,135	4,718	4,750	4,641	4,761	4,586	4,821	4,878	5,087	4,706	5,045	4,990	5,437	5,168	5,272	5,509	5,890	5,252	4,714	4,983	20,839
Cost of Revenue	1,679	1,470	1,537	1,532	1,612	1,527	2,616	2,262	2,311	2,187	2,221	2,276	2,318	2,247	2,520	2,195	2,578	2,583	2,661	2,649	2,848	2,498	2,637	2,574	2,684	2,453	2,586	2,778	3,386	2,679	2,741	2,683	2,950	2,933	3,015	2,875	3,092	2,908	2,560	2,668	11,228
Gross Profit	1,552	1,452	1,432	1,503	1,554	1,553	1,606	2,016	2,091	1,973	1,974	2,074	2,266	1,978	1,733	1,660	2,206	2,732	2,246	1,958	2,287	2,220	2,113	2,067	2,077	2,133	2,235	2,100	1,701	2,027	2,304	2,307	2,487	2,235	2,257	2,634	2,798	2,344	2,154	2,315	9,611
Research & Development	253	182	187	186	220	191	259	277	278	258	252	282	270	270	264	262	299	291	317	330	387	314	327	315	300	313	337	306	281	290	299	299	302	343	302	297	322	318	249	258	1,147
Selling, General & Administrative	796	709	724	719	774	774	1,057	1,081	1,103	1,073	1,089	1,076	1,096	1,121	1,025	980	1,192	1,149	1,148	1,237	1,332	1,223	1,232	1,149	1,182	1,187	1,205	1,190	1,137	1,213	1,193	1,196	1,256	1,318	1,273	1,320	1,366	1,432	1,213	1,261	5,272
Total Operating Expenses	1,456	641	986	1,726	1,111	1,318	1,420	1,504	1,520	1,085	1,838	1,448	2,155	1,477	1,363	1,302	1,951	1,491	1,812	1,466	1,792	1,528	1,549	1,530	1,588	1,548	1,607	1,551	1,352	1,588	1,570	1,705	1,865	1,782	1,711	1,752	2,102	1,750	2,061	1,652	7,565
Operating Income	96	811	446	-223	443	235	186	512	571	888	136	626	111	501	370	358	255	1,241	434	492	495	692	564	537	489	585	628	549	349	439	734	602	622	453	546	882	697	594	94	663	2,048
Interest Expense	95	95	86	184	157	158	185	182	181	183	171	156	141	136	134	135	123	118	124	115	111	98	97	99	104	102	118	119	113	111	125	137	155	155	151	152	155	107	149	132	543
Pre-Tax Income	9.0	692	362	-404	326	105	6.0	647	414	714	3.0	460	-2.0	394	200	248	143	1,157	305	378	266	600	442	421	320	481	529	471	181	359	633	500	514	306	363	703	510	487	39	554	1,590
Income Tax Expense	-10	131	18	-271	-1.0	241	18	53	549	115	-17	9.0	-164	117	17	-38	15	154	6.0	-28	1.0	32	52	31	33	-28	68	64	27	77	96	13	114	3.0	55	129	17	105	76	103	301
Net Income	19	562	344	-132	327	-136	-12	594	-135	599	20	451	162	278	183	286	128	1,003	299	525	265	677	454	360	288	509	460	407	108	281	537	487	400	303	308	574	493	382	-311	377	941
EBITDA	377	1,049	709	59	769	554	744	1,397	1,161	1,460	737	1,190	692	1,060	871	917	819	1,830	987	1,028	969	1,244	1,087	1,074	1,005	1,150	1,210	1,161	881	1,031	1,329	1,205	1,255	1,068	1,122	1,473	1,294	1,208	709	686	3,897

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings